An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of AD-117 in Healthy Adult Volunteers
Latest Information Update: 02 Apr 2026
At a glance
- Drugs AD-117 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Addpharma
Most Recent Events
- 02 Apr 2026 New trial record